Study Stopped
decided to shift to a new design and measures
Time-Restricted Eating and Bipolar Disorder
Time-Restricted Eating as an Adjunctive Intervention for Bipolar Disorder: Acceptability and Feasibility
1 other identifier
interventional
1
1 country
1
Brief Summary
This is a pilot trial to examine the acceptability and feasibility of time-restricted eating as an adjunct to medication treatment for bipolar disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2023
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedFirst Posted
Study publicly available on registry
October 27, 2023
CompletedOctober 27, 2023
October 1, 2023
2 months
February 6, 2023
October 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Acceptability as assessed using self-ratings on items designed for this study
self-ratings of the acceptability of the intervention
Immediately post-treatment (10 weeks)
Feasibility as assessed by percent of clients who complete the assessments and intervention
Percentage of clients who do not drop out of the trial. Drop out would be defined as not completing the TRE intervention, or failing to complete the end-of-treatment intervention.
Immediately post-treatment (10 weeks)
Secondary Outcomes (4)
Lower Mania symptoms as assessed with the Patient Mania Questionnaire-9
Change from baseline to immediately post-treatment (10 weeks)
Lower Depression symptoms as assessed with the Patient Health Questionnaire-9
Change from baseline to immediately post-treatment (10 weeks)
Lower scores on two Patient Reported Outcome Measurement Information System (PROMIS) sleep scales
Change from baseline to immediately post-treatment (10 weeks)
higher scores on Self-rated Quality of Life
Change from baseline to immediatly post-treatment (10 weeks)
Other Outcomes (1)
Higher Functional impairment on the World Health Organization Disability Assessment Schedule (WHO-DAS2.0)
Change from baseline to immediatly post-treatment (10 weeks)
Study Arms (1)
time-restricted eating
EXPERIMENTALPost-baseline, participants will be asked to restrict their eating to a 10-hour window.
Interventions
Eligibility Criteria
You may qualify if:
- adults diagnosed with bipolar disorder and currently receiving medical care for their bipolar disorder.
- Experiencing schedule/sleep or circadian problem in the past 3 months
- Medication regimens stable for past month
- Adequate English language skills for taking part in the program.
- Living in California.
You may not qualify if:
- Cognitive deficits (Screening OMC Test)
- Current: psychosis, (hypo)mania, major depressive episode, substance/alcohol use disorders, eating disorder diagnoses or acute suicidal risk (MINI interview; see DSM5 TRE screening)
- High scores (\> 5) on the Screening Eating Disorder Examination Questionnaire
- Current shift work
- \>5 kg weight change within 3 months
- Pregnancy
- Breastfeeding
- Uncorrected hypo or hyperthyroidism
- \* diabetes type 1
- Gastrointestinal conditions impairing nutrient absorption
- Medications contraindicated for fasting, including clozapine, glucose-lowering medications, diabetes-related injections, requiring food early morning or late evening, corticosteroids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California
Berkeley, California, 94720, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2023
First Posted
October 27, 2023
Study Start
June 1, 2023
Primary Completion
July 31, 2023
Study Completion
July 31, 2023
Last Updated
October 27, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Within one year of study completion, if ethics board approves.
- Access Criteria
- Available through OSF.
De-identified data will be available at OSF post-study.